Journal of Commercial Biotechnology — January 2010 issue now available

January 7, 2010

The January 2010 issue of the Journal of Commercial Biotechnology is now available. The links below will take you to the abstract for each paper:

Volume 16, Issue 1

Time for a new business model? (free full-text)
Yali Friedman

Why data exclusivity is the new patent protection
Peter Pitts

Follow-on biologic drug competition – No need for new marketing exclusivities
Michael S Wroblewski and Elizabeth A Jex

Pharmaceutical royalties in licensing deals: No place for the 25 per cent rule of thumb
Nigel Borshell and Adrian Dawkes

Exploring technology agglomeration patterns for multinational pharmaceutical and biotechnology firms
Mark J Ahn, Michael Meeks, Sally Davenport and Rebecca Bednarek

Intellectual property landscape and patenting opportunity in biofuels
Ramasamy Mannan

Challenges and opportunities in the licensing of renewable technologies
Meredith Lloyd-Evans, Mike Gilbert and Ilian P Iliev

Ethiopia: Biotechnology for development
Desta Berhe Sbhatu

Innovation and commercialisation in the stem cell industries in Australia: State strategies and other opportunities to build a competitive position in the global stem cell economy
Olivia Harvey

Book Review: Health-care investing: Profiting from the new world of pharma, biotech and health-care services
Frank LaSaracina

Book Review: Aging, Biotechnology, and the Future
Harley King

Using IP audits to optimize IP assets
James G Cullem

Share this page
[Bloglines] [del.icio.us] [Digg] [Facebook] [Google] [LinkedIn] [Reddit] [StumbleUpon] [Twitter] [Email]

Leave a Comment

{ 1 trackback }

Previous post:

Next post: